Immunotherapy Rechallenge Successful in Some Cancer Patients

Patients treated with anti –PD-1 or anti–PD-L1 inhibitors in clinical trials were successfully retreated with the inhibitors after discontinuing the treatment.

Source: CancerNetwork - August 10, 2018 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news